Search Orphan Drug Designations and Approvals
-
| Generic Name: | adeno-associated virus serotype rh.10 encoding for the human PKP2 gene (AAVrh.10hPKP2) |
|---|---|
| Date Designated: | 12/14/2023 |
| Orphan Designation: | Treatment of arrhythmogenic cardiomyopathy due to a PKP2 pathogenic variant |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
LEXEO Therapeutics, Inc. 345 Park Avenue South, 6th Floor New York, New York 10010 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







